SP
NBP icon

Sage Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Sage Partners’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$9.48M – 2
2021
Q4 		$9.48M Buy
+200,000
New +$12M 73.13% 1

Other funds holding NBP

HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cederberg Capital
Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sage Partners's NBP Position: Q1 2022 in Review

Sage Partners sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 200,000 shares — an estimated $9.48M sold.

Sage Partners first reported a position in NBP in Q4 2021 and held it in 1 quarter. The position peaked at $9.48M in Q4 2021. 119 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • Sage Partners reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Sage Partners sold 200,000 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $9.48M.
  • Sage Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Sage Partners's NovaBridge Biosciences American Depositary Shares position peaked at $9.48M in Q4 2021.
  • 119 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Sage Partners's 13F filing for Q1 2022.